A core needle biopsy confirmed TNBC with estrogen receptor (ER) negative, progesterone receptor (PR) negative, and HER2 negative, which is histologically a poorly differentiated invasive ductal carcinoma. Here, ESR1 is linked to invasive ductal breast carcinoma.